A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects

NCT05895565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

IPF

Interventions

DRUG: PMG1015
DRUG: PMG1015 placebo

Sponsor

Pulmongene Ltd.